spironolactone has been researched along with Aldosteronism with Hyperplasia of the Adrenal Cortex in 50 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Six adult patients (4 females and 2 males, age range 26-57 years) with Gitelman's syndrome (GS) were treated with spironolactone 200-300 mg/day (n = 5) and/or amiloride 10-30 mg/day (n = 3) for 1-18 months." | 7.69 | Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. ( Colussi, G; De Ferrari, ME; Macaluso, M; Minetti, L; Rombolà, G, 1994) |
| " The short-term (9 days) effect of indomethacin in combination with spironolactone was a suppression of hyperreninemia and hyperaldosteronism and an increase in vascular sensitivity to angiotensin II associated with potassium and sodium retention." | 7.66 | Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin. ( Kornerup, HJ; Pedersen, EB; Petersen, VP, 1978) |
| "During treatment with indomethacin in a patient with Bartter's syndrome, hypokalemia, high plasma renin concentration, hyperaldosteronism and decreased sensitivity to angiotensin infusion were corrected." | 7.65 | Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. ( Amery, A; Clement, J; Michielsen, P; van Damme B, B; Verberckmoes, R, 1976) |
| " She was diagnosed to have Gitelman's syndrome with chondrocalcinosis, which were effectively treated with spironolactone and magnesium supplementation." | 3.70 | A case of Gitelman's syndrome with chondrocalcinosis. ( Hashimoto, K; Hisakawa, N; Itoh, H; Jinnouchi, C; Nishiya, K; Takao, T; Yasuoka, N, 1998) |
| "Six adult patients (4 females and 2 males, age range 26-57 years) with Gitelman's syndrome (GS) were treated with spironolactone 200-300 mg/day (n = 5) and/or amiloride 10-30 mg/day (n = 3) for 1-18 months." | 3.69 | Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. ( Colussi, G; De Ferrari, ME; Macaluso, M; Minetti, L; Rombolà, G, 1994) |
| " In six patients with Bartter's syndrome, four with pseudo-Bartter's syndrome, and twenty with essential hypertension (EH) chronically treated with chlorthalidone, serum potassium (serum K+) and extracellular fluid volume (ECFV) were decreased, while plasma volume (PV) and blood volume (BV) were normal (see Table 1 for means, standard deviations, and levels of significance)." | 3.67 | Blood to interstitial fluid volume ratio in chronic hypokalaemic states. ( Boer, P; Dorhout Mees, EJ; Geyskes, GG; Hené, RJ; Koomans, HA; Roos, JC; Van Shaik, BA, 1985) |
| " The short-term (9 days) effect of indomethacin in combination with spironolactone was a suppression of hyperreninemia and hyperaldosteronism and an increase in vascular sensitivity to angiotensin II associated with potassium and sodium retention." | 3.66 | Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin. ( Kornerup, HJ; Pedersen, EB; Petersen, VP, 1978) |
| "During treatment with indomethacin in a patient with Bartter's syndrome, hypokalemia, high plasma renin concentration, hyperaldosteronism and decreased sensitivity to angiotensin infusion were corrected." | 3.65 | Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. ( Amery, A; Clement, J; Michielsen, P; van Damme B, B; Verberckmoes, R, 1976) |
| "Bartter syndrome is a rare hereditary salt-losing tubulopathy caused by mutations of several genes in the thick ascending limb of Henle's loop, characterized by polyuria, hypokalemic metabolic alkalosis, growth retardation and normal blood pressure." | 2.94 | Adjunctive acetazolamide therapy for the treatment of Bartter syndrome. ( Assadi, F; Mazaheri, M; Sadeghi-Bojd, S, 2020) |
| "For the first time neonatal variant of Bartter syndrome to 14." | 2.42 | [Bartter syndrome and it's neonatal type]. ( Jakutovic, M; Jankauskiene, A, 2003) |
| "Inherited classic Bartter syndrome (cBS) is an autosomal recessive renal tubular disorder resulting from inactivating mutations in the asolateral chloride channel (C1C-Kb) and usually presents in early infancy or childhood with mild to moderate hypokalemia." | 1.40 | Hypokalemic paralysis in a middle-aged female with classic Bartter syndrome. ( Chan, JS; Chiang, WF; Lin, SH, 2014) |
| "Here we report a patient with Bartter's syndrome and empty sella." | 1.32 | Association of Bartter's syndrome and empty sella. ( Ertekin, V; Orbak, Z; Selimoglu, AM, 2003) |
| "African Americans with Bartter syndrome genotyped to date have homozygous deletion of ClC-Kb Clinical observations in our patients include partial correction of hypokalemia and suboptimal growth despite therapy." | 1.31 | Genotype/phenotype observations in African Americans with Bartter syndrome. ( Campos, A; Cruz, DN; Garin, EH; Perlman, SA; Schurman, SJ; Shoemaker, LR; Sutphen, R, 2001) |
| "A case of neonatal Bartter syndrome is reported." | 1.31 | Neonatal Bartter syndrome. ( Bavdekar, SB; Kabde, U; Kantharia, VC; Muranjan, MN; Parmar, RC, 2002) |
| "Fifteen patients with Bartter's syndrome (hyponatremic hypochloremic hypokalemic metabolic alkalosis) were compared with 15 healthy volunteers." | 1.30 | Membrane ion transport in Bartter's syndrome: evidence for a new syndrome subtype. ( Koren, W; Peleg, E; Postnov, YV; Rosenthal, T, 1997) |
| "Bartter's Syndrome is characterized by renal potassium wasting with hypokalemia, metabolic alkalosis, increased renin-angiotensin-aldosterone system, normal blood pressure, resistance to the pressor effects of angiotensin II and juxtaglomerular cell hyperplasia." | 1.29 | A case of adult-onset Bartter's syndrome. ( Choi, KC; Chung, YJ; Kang, YJ; Kim, NH; Kim, SW; Lee, JJ; Park, JW; Yeum, CH; Yoo, KS, 1995) |
| "On the other hand, hypopotassemia (2." | 1.28 | [A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia]. ( Bando, Y; Kobayashi, K; Miyakoshi, H; Nagaoka, T; Ohsawa, K, 1992) |
| "The treatment of Bartter's syndrome is fraught with difficulties, and there is no consensus concerning the pathogenetic mechanisms involved." | 1.28 | Bartter's syndrome--treatment with potassium, spironolactone and ACE-inhibitor. ( Christensen, P; Clementsen, P; Damkjaer, M; Giese, J; Hansen, CL; Høegholm, A, 1989) |
| "Serum of patients with Bartter's syndrome incubated with healthy RBC distinctly increased their 86Rb influx." | 1.27 | The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome. ( Dvoráková, J; Horký, K; Schreiber, V, 1984) |
| "In other words, the Bartter's syndrome or the hypopotassemia should be one of the fundamental disorders for developing tetanic symptom." | 1.27 | [Development of tetany in siblings suffered from Bartter's syndrome]. ( Kimura, S; Kita, S; Okamoto, S; Shiozaki, Y; Suitsu, N, 1984) |
| "Treatment with spironolactone together with potassium led to impressive catch-up growth." | 1.27 | Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome. ( Massa, G; Proesmans, W; Vanderschueren-Lodeweyckx, M, 1988) |
| "Potassium chloride was most effective in raising the serum potassium level during the first 4 weeks of administration." | 1.26 | Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride. ( Abe, K; Chiba, S; Haruyama, T; Kabuki, J; Otsuka, Y; Saito, T; Sato, M; Yasujima, M; Yoshinaga, K, 1980) |
| "The diagnosis of Bartter's syndrome was made in a 9-month-old boy investigated for poor weight and height gain." | 1.26 | Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors. ( Lee, MR; Littlewood, JM; Meadow, SR, 1978) |
| "When ibuprofen was added to this regimen, potassium supplements were no longer required." | 1.26 | Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome. ( Berger, M; Brouhard, BH; Cunningham, RJ; Petrusick, T; Travis, LB, 1979) |
| "In an 18-year-old boy with Bartter's syndrome, hypophosphatemia was discovered (2." | 1.26 | Hypophosphatemia and hyperparathyroidism in a case of Bartter's syndrome. ( Bernheim, J; David, L; François, R; Sann, L, 1978) |
| "A 63-year-old man had asymptomatic Bartter's syndrome, discovered during evaluation for hypokalemia." | 1.26 | Asymptomatic Bartter's syndrome. ( Barbour, GL; Day, JO, 1978) |
| "The hyperreninemia and hyperaldosteronism were both suppressible with volume expansion." | 1.25 | Bartter's syndrome. New insights into pathogenesis and treatment. ( Brown, RS; Solomon, RJ, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (56.00) | 18.7374 |
| 1990's | 12 (24.00) | 18.2507 |
| 2000's | 6 (12.00) | 29.6817 |
| 2010's | 2 (4.00) | 24.3611 |
| 2020's | 2 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kucuk, N | 1 |
| Yavas Abalı, Z | 1 |
| Abalı, S | 1 |
| Canpolat, N | 1 |
| Yesil, G | 1 |
| Turan, S | 1 |
| Bereket, A | 1 |
| Guran, T | 1 |
| Mazaheri, M | 1 |
| Assadi, F | 1 |
| Sadeghi-Bojd, S | 1 |
| Sundar, U | 1 |
| Lakkas, Y | 1 |
| Asole, D | 1 |
| Vaidya, M | 1 |
| Chiang, WF | 1 |
| Lin, SH | 2 |
| Chan, JS | 1 |
| Jankauskiene, A | 1 |
| Jakutovic, M | 1 |
| Ertekin, V | 1 |
| Selimoglu, AM | 1 |
| Orbak, Z | 1 |
| Ea, HK | 1 |
| Blanchard, A | 1 |
| Dougados, M | 1 |
| Roux, C | 1 |
| Horký, K | 1 |
| Schreiber, V | 1 |
| Dvoráková, J | 1 |
| Suitsu, N | 1 |
| Kita, S | 1 |
| Okamoto, S | 1 |
| Kimura, S | 1 |
| Shiozaki, Y | 1 |
| Sasaki, H | 1 |
| Kawasaki, T | 1 |
| Okumura, M | 1 |
| Asano, T | 1 |
| Abe, K | 2 |
| Arakawa, K | 1 |
| Chan, JC | 1 |
| Cooper, SM | 1 |
| Sato, M | 1 |
| Yasujima, M | 1 |
| Otsuka, Y | 1 |
| Chiba, S | 1 |
| Haruyama, T | 1 |
| Yoshinaga, K | 1 |
| Saito, T | 1 |
| Kabuki, J | 1 |
| Nakada, T | 1 |
| Shigematsu, H | 1 |
| Bartter, FC | 2 |
| Delea, CS | 1 |
| Park, JW | 1 |
| Chung, YJ | 1 |
| Yeum, CH | 1 |
| Lee, JJ | 1 |
| Yoo, KS | 1 |
| Kim, SW | 1 |
| Kim, NH | 1 |
| Choi, KC | 1 |
| Kang, YJ | 1 |
| Groves, TD | 1 |
| Corenblum, B | 1 |
| Colussi, G | 2 |
| Rombolà, G | 2 |
| De Ferrari, ME | 1 |
| Macaluso, M | 1 |
| Minetti, L | 2 |
| Rigó, J | 1 |
| Gláz, E | 1 |
| Papp, Z | 1 |
| Bień, B | 1 |
| Lamnari, AM | 1 |
| Górska, M | 1 |
| Mendonca, E | 1 |
| Albuquerque, L | 1 |
| Jacome, L | 1 |
| Luis, ML | 1 |
| Rosa, FC | 1 |
| Nakagawa, Y | 1 |
| Toya, K | 1 |
| Natsume, H | 1 |
| Nasuda, K | 1 |
| Takeuchi, H | 1 |
| Kubota, A | 1 |
| Ogawa, H | 1 |
| Igarashi, Y | 1 |
| Koren, W | 1 |
| Peleg, E | 1 |
| Rosenthal, T | 1 |
| Postnov, YV | 1 |
| Hisakawa, N | 1 |
| Yasuoka, N | 1 |
| Itoh, H | 1 |
| Takao, T | 1 |
| Jinnouchi, C | 1 |
| Nishiya, K | 1 |
| Hashimoto, K | 1 |
| Deliyska, B | 1 |
| Lazarov, V | 1 |
| Minkova, V | 1 |
| Nikolov, D | 1 |
| Tishkov, I | 1 |
| Schurman, SJ | 1 |
| Perlman, SA | 1 |
| Sutphen, R | 1 |
| Campos, A | 1 |
| Garin, EH | 1 |
| Cruz, DN | 1 |
| Shoemaker, LR | 1 |
| Muranjan, MN | 1 |
| Kantharia, VC | 1 |
| Bavdekar, SB | 1 |
| Kabde, U | 1 |
| Parmar, RC | 1 |
| Rössler, R | 1 |
| Littlewood, JM | 1 |
| Lee, MR | 1 |
| Meadow, SR | 1 |
| Cunningham, RJ | 1 |
| Brouhard, BH | 1 |
| Berger, M | 1 |
| Petrusick, T | 1 |
| Travis, LB | 1 |
| Ishikawa, Y | 1 |
| Wada, T | 1 |
| Delaporte, C | 1 |
| Stulzaft, J | 1 |
| Loirat, C | 1 |
| Broyer, M | 1 |
| Simatupang, TA | 1 |
| Radó, JP | 1 |
| Boer, P | 2 |
| Geyskes, GG | 2 |
| Vos, J | 1 |
| Dorhout Mees, EJ | 2 |
| López, JM | 1 |
| Rodríguez, JA | 1 |
| Rosenberg, H | 1 |
| Atria, P | 1 |
| Takahashi, H | 1 |
| Yoshimura, M | 1 |
| Ijichi, H | 1 |
| Cordone, G | 1 |
| Fasce, L | 1 |
| Gianfranceschi, P | 1 |
| Delucchi, M | 1 |
| Iester, A | 1 |
| Torcia, R | 1 |
| Kornerup, HJ | 1 |
| Pedersen, EB | 1 |
| Petersen, VP | 1 |
| Sann, L | 1 |
| David, L | 1 |
| Bernheim, J | 1 |
| François, R | 1 |
| Barbour, GL | 1 |
| Day, JO | 1 |
| Verberckmoes, R | 1 |
| van Damme B, B | 1 |
| Clement, J | 1 |
| Amery, A | 1 |
| Michielsen, P | 1 |
| Schwartz, GJ | 1 |
| Cornfeld, D | 1 |
| Solomon, RJ | 1 |
| Brown, RS | 1 |
| Maesaka, H | 1 |
| Nishibatake, S | 1 |
| Suwa, S | 1 |
| Yabuta, K | 1 |
| Verde, G | 1 |
| Airaghi, C | 1 |
| Loli, P | 1 |
| Bando, Y | 1 |
| Miyakoshi, H | 1 |
| Nagaoka, T | 1 |
| Ohsawa, K | 1 |
| Kobayashi, K | 1 |
| de Heide, LJ | 1 |
| Birkenhäger, JC | 1 |
| Clementsen, P | 1 |
| Høegholm, A | 1 |
| Hansen, CL | 1 |
| Damkjaer, M | 1 |
| Christensen, P | 1 |
| Giese, J | 1 |
| Proesmans, W | 1 |
| Massa, G | 1 |
| Vanderschueren-Lodeweyckx, M | 1 |
| Koomans, HA | 1 |
| Hené, RJ | 1 |
| Van Shaik, BA | 1 |
| Roos, JC | 1 |
| Topf, G | 1 |
| Zech, P | 1 |
| Pozet, N | 1 |
| Sassard, J | 1 |
| Leitienne, P | 1 |
| Blanc, N | 1 |
| Colon, S | 1 |
| Berthoux, F | 1 |
| Touraine, JL | 1 |
| Traeger, J | 1 |
2 reviews available for spironolactone and Aldosteronism with Hyperplasia of the Adrenal Cortex
| Article | Year |
|---|---|
[Bartter syndrome and it's neonatal type].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bartter Syndrome; Bone Diseases, Metabolic; Cal | 2003 |
Bartter's syndrome.
Topics: Adrenalectomy; Bartter Syndrome; Humans; Hyperaldosteronism; Prostaglandin Antagonists; Prostaglandi | 1977 |
1 trial available for spironolactone and Aldosteronism with Hyperplasia of the Adrenal Cortex
| Article | Year |
|---|---|
Adjunctive acetazolamide therapy for the treatment of Bartter syndrome.
Topics: Acetazolamide; Antihypertensive Agents; Bartter Syndrome; Carbonic Anhydrase Inhibitors; Child, Pres | 2020 |
47 other studies available for spironolactone and Aldosteronism with Hyperplasia of the Adrenal Cortex
| Article | Year |
|---|---|
A rare cause of hypertension in childhood: Answers.
Topics: Aldosterone; Alkalosis; Bartter Syndrome; Child; Child, Preschool; Consanguinity; Cortisone; Diagnos | 2020 |
Gitelman's syndrome presenting as recurrent paralytic ileus due to chronic renal tubular K+ wasting.
Topics: Alkalosis; Bartter Syndrome; Calcium; Chronic Disease; Diagnosis, Differential; Diuretics; Gitelman | 2010 |
Hypokalemic paralysis in a middle-aged female with classic Bartter syndrome.
Topics: Bartter Syndrome; Chloride Channels; Dietary Supplements; Diuretics; Female; Genetic Predisposition | 2014 |
Association of Bartter's syndrome and empty sella.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bartter Syndrome; Blood Pressure; Empty Sella Syndrome; Hum | 2003 |
Chondrocalcinosis secondary to hypomagnesemia in Gitelman's syndrome.
Topics: Bartter Syndrome; Blood Chemical Analysis; Bone Density; Chondrocalcinosis; Drug Therapy, Combinatio | 2005 |
The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
Topics: Adult; Aldosterone; Bartter Syndrome; Erythrocytes; Humans; Hyperaldosteronism; Ion Channels; Potass | 1984 |
[Development of tetany in siblings suffered from Bartter's syndrome].
Topics: Adult; Bartter Syndrome; Biopsy; Calcium; Female; Humans; Hyperaldosteronism; Hypokalemia; Kidney; M | 1984 |
Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Aldosterone; Aminoglutethimide; Angiotensin II; Aspi | 1980 |
Bartter's syndrome.
Topics: Aldosterone; Bartter Syndrome; Brain Diseases, Metabolic; Child, Preschool; Electrolytes; Humans; Hy | 1981 |
Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
Topics: Adult; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Indomethacin; Male; Potassium Chloride; | 1980 |
Nephropathologic characteristics of a woman with Bartter's syndrome after prolonged treatment with spironolactone.
Topics: Adult; Bartter Syndrome; Biopsy, Needle; Female; Humans; Hyperaldosteronism; Juxtaglomerular Apparat | 1980 |
A case of adult-onset Bartter's syndrome.
Topics: Adult; Bartter Syndrome; Enalapril; Female; Humans; Indomethacin; Potassium Chloride; Propranolol; S | 1995 |
Spironolactone therapy during human pregnancy.
Topics: Adolescent; Adult; Bartter Syndrome; Child; Female; Humans; Male; Pregnancy; Pregnancy Complications | 1995 |
Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome.
Topics: Adult; Aldosterone; Amiloride; Bartter Syndrome; Blood Gas Analysis; Blood Pressure; Creatinine; Dru | 1994 |
Low or high doses of spironolactone for treatment of maternal Bartter's syndrome.
Topics: Bartter Syndrome; Female; Humans; Pregnancy; Pregnancy Complications; Spironolactone | 1996 |
[Hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria; Bartter's syndrome in Gitelman's variant--case report].
Topics: Adult; Alkalosis; Bartter Syndrome; Humans; Hypokalemia; Indomethacin; Magnesium; Male; Potassium; P | 1995 |
Pseudotumor cerebri in a patient with Bartter's syndrome and obesity.
Topics: Adolescent; Bartter Syndrome; Female; Hematologic Tests; Humans; Indomethacin; Obesity; Potassium Ch | 1996 |
Long-term follow-up of a girl with the neonatal form of Bartter's syndrome.
Topics: Angiotensin I; Angiotensin II; Bartter Syndrome; Female; Follow-Up Studies; Growth; Humans; Indometh | 1997 |
Membrane ion transport in Bartter's syndrome: evidence for a new syndrome subtype.
Topics: Adolescent; Adult; Bartter Syndrome; Biological Transport; Calcium; Calmodulin; Carrier Proteins; Ch | 1997 |
A case of Gitelman's syndrome with chondrocalcinosis.
Topics: Bartter Syndrome; Calcium; Chondrocalcinosis; Diagnosis, Differential; Female; Humans; Hypokalemia; | 1998 |
Association of Bartter's syndrome with vasculitis.
Topics: Adult; Bartter Syndrome; Cyclophosphamide; Female; Humans; Methylprednisolone; Mineralocorticoid Rec | 2000 |
Genotype/phenotype observations in African Americans with Bartter syndrome.
Topics: Anion Transport Proteins; Bartter Syndrome; Black People; Calcium; Chloride Channels; DNA Mutational | 2001 |
Neonatal Bartter syndrome.
Topics: Administration, Oral; Bartter Syndrome; Diagnosis, Differential; Diuretics; Female; Humans; Infant; | 2002 |
[Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Bartter Syndrome; Dexamethasone; Glucocort | 1975 |
Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors.
Topics: Bartter Syndrome; Body Height; Body Weight; Child, Preschool; Cyclooxygenase Inhibitors; Humans; Hyp | 1978 |
Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
Topics: Adolescent; Bartter Syndrome; Child; Child, Preschool; Drug Therapy, Combination; Growth; Humans; Hy | 1979 |
Escape from sodium and potassium retaining actions of aspirin-like drugs used in a patient with Bartter's syndrome.
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Bartter Syndrome; Humans; Hyperaldosteronism; Ibuprofen; I | 1979 |
Muscle electrolytes and fluid compartments in six children with Bartter's syndrome.
Topics: Bartter Syndrome; Child; Child, Preschool; Chlorides; Female; Humans; Hyperaldosteronism; Male; Musc | 1978 |
Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
Topics: Adult; Amiloride; Bartter Syndrome; Humans; Hyperaldosteronism; Ibuprofen; Indomethacin; Male; Potas | 1978 |
[Bartter's syndrome, with limited response to adrenalectomy].
Topics: Adrenalectomy; Adult; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Hypokalemia; Juxtaglomer | 1978 |
[Bartter's syndrome--studies on a patient with evidence for excessive prostaglandin synthesis (author's transl)].
Topics: Bartter Syndrome; Humans; Hyperaldosteronism; Indomethacin; Male; Middle Aged; Propranolol; Prostagl | 1978 |
[Bartter's syndrome. Current prospects of nosographic classification and new therapeutic possibilities].
Topics: Aldosterone; Bartter Syndrome; Child; Electrolytes; Female; Humans; Hyperaldosteronism; Indomethacin | 1978 |
Bartter's syndrome without hyperplasia of the juxtaglomerular apparatus, treated with indomethacin.
Topics: Adult; Bartter Syndrome; Diet, Sodium-Restricted; Drug Evaluation; Humans; Hyperaldosteronism; Hyper | 1978 |
Hypophosphatemia and hyperparathyroidism in a case of Bartter's syndrome.
Topics: Adolescent; Alkalosis; Bartter Syndrome; Humans; Hyperaldosteronism; Hyperparathyroidism; Hypokalemi | 1978 |
Asymptomatic Bartter's syndrome.
Topics: Angiotensin II; Bartter Syndrome; Drug Therapy, Combination; Humans; Hyperaldosteronism; Hypokalemia | 1978 |
Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.
Topics: Adult; Bartter Syndrome; Body Weight; Dose-Response Relationship, Drug; Humans; Hyperaldosteronism; | 1976 |
Bartter's syndrome: clinical study of its treatment with salt loading and propranolol.
Topics: Bartter Syndrome; Child; Child, Preschool; Follow-Up Studies; Humans; Hyperaldosteronism; Infant; Ma | 1975 |
Bartter's syndrome. New insights into pathogenesis and treatment.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Volume; Female; Humans; Hyperaldosteroni | 1975 |
[Case of Bartter syndrome].
Topics: Bartter Syndrome; Child, Preschool; Humans; Hyperaldosteronism; Male; Parathyroid Hormone; Propranol | 1975 |
Distal nephron function in Bartter's syndrome: abnormal conductance to chloride in the cortical collecting tubule?
Topics: Adolescent; Adult; Amiloride; Bartter Syndrome; Diuresis; Female; Fludrocortisone; Furosemide; Human | 1992 |
[A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia].
Topics: Adult; Bartter Syndrome; Female; Humans; Hydroxycholecalciferols; Hypokalemia; Parathyroid Hormone; | 1992 |
Bartter's syndrome, hypomagnesaemia and chondrocalcinosis.
Topics: Bartter Syndrome; Chondrocalcinosis; Female; Humans; Magnesium; Middle Aged; Spironolactone | 1991 |
Bartter's syndrome--treatment with potassium, spironolactone and ACE-inhibitor.
Topics: Adult; Bartter Syndrome; Captopril; Drug Therapy, Combination; Female; Humans; Hyperaldosteronism; P | 1989 |
Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome.
Topics: Adolescent; Adult; Bartter Syndrome; Calcium; Child; Child, Preschool; Diuresis; Electrolytes; Femal | 1988 |
Blood to interstitial fluid volume ratio in chronic hypokalaemic states.
Topics: Bartter Syndrome; Blood Volume; Chlorthalidone; Chronic Disease; Extracellular Space; Female; Humans | 1985 |
[Barrter's syndrome].
Topics: Anorexia Nervosa; Bartter Syndrome; Humans; Hyperaldosteronism; Prognosis; Spironolactone; Triamtere | 1974 |
[Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
Topics: Adult; Aldosterone; Bartter Syndrome; Biological Transport, Active; Biopsy; Humans; Hyperaldosteroni | 1974 |